You can purchase shares of Relay Therapeutics (NASDAQ:RLAY) through any online brokerage.

View our list of the best stock brokerages

Other companies in Relay Therapeutics’s space includes: Ultragenyx Pharmaceutical Inc (NASDAQ:RARE), Mesoblast Ltd (NASDAQ:MESO), AnaptysBio Inc (NASDAQ:ANAB), Agios Pharmaceuticals Inc (NASDAQ:AGIO) and Tyra Biosciences Inc (NASDAQ:TYRA).

Relay Therapeutics has a consensus price target of $17.50.

The stock price for Relay Therapeutics (NASDAQ: RLAY) is $10.08 last updated March 26, 2026 at 3:38 PM EDT.

There are no upcoming dividends for Relay Therapeutics.

Relay Therapeutics does not have any upcoming earnings scheduled.

There is no upcoming split for Relay Therapeutics.

Relay Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.